Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

NNatera, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
N

Natera, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions

News

News

  • Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer
    Sep 22, 2026Natera, Inc. Press Releases
  • Largest MRD Study in Lung Cancer Highlights Strong Prognostic Value for Signatera™
    Sep 18, 2026Natera, Inc. Press Releases
  • New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in Lymphoma
    Sep 1, 2026Natera, Inc. Press Releases
  • Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer
    Aug 28, 2026Natera, Inc. Press Releases
  • Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™
    Aug 27, 2026Natera, Inc. Press Releases
  • Natera to Support New Clinical Trial Assessing ctDNA Dynamics with Latitude™ in Advanced Skin Cancers
    Aug 12, 2026Natera, Inc. Press Releases
  • Natera Reports Second Quarter 2026 Financial Results
    Aug 6, 2026Natera, Inc. Press Releases
  • Natera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer
    Aug 5, 2026Natera, Inc. Press Releases
  • Natera to Report its Second Quarter Results on August 6, 2026
    Jul 30, 2026Natera, Inc. Press Releases
  • Signatera™ MRD Outperformed AMERK Testing in Predicting Merkel Cell Carcinoma Recurrence in JAMA Dermatology Study
    Jul 22, 2026Natera, Inc. Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • News
  • Insider Transactions
$390.90Close · Sep 22, 2026